Met Life Investment Management, LLC Amicus Therapeutics, Inc. Transaction History

Met Life Investment Management, LLC

  • $18 Billion
  • Q4 2024

A detailed history of Met Life Investment Management, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 179,555 shares of FOLD stock, worth $1.23 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
179,555
Previous 169,499 5.93%
Holding current value
$1.23 Million
Previous $1.81 Million 6.57%
% of portfolio
0.01%
Previous 0.01%

Shares

48 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$9.36 - $12.01 $94,124 - $120,772
10,056 Added 5.93%
179,555 $1.69 Million
Q2 2024

Aug 13, 2024
BUY
$9.04 - $11.75 $220,476 - $286,570
24,389 Added 16.81%
169,499 $1.68 Million
Q1 2024

May 14, 2024
BUY
$11.43 - $14.24 $1.66 Million - $2.07 Million
145,110 New
145,110 $1.71 Million
Q3 2023

May 09, 2024
BUY
$11.78 - $13.86 $26,422 - $31,087
2,243 Added 1.53%
148,666 $1.81 Million
Q2 2023

Apr 29, 2024
BUY
$10.72 - $13.3 $1.59 Million - $1.98 Million
148,666 New
148,666 $1.87 Million
Q2 2023

Aug 10, 2023
BUY
$10.72 - $13.3 $24,044 - $29,831
2,243 Added 1.53%
148,666 $1.87 Million
Q1 2023

May 09, 2024
BUY
$10.91 - $13.54 $1.6 Million - $1.98 Million
146,423 New
146,423 $1.62 Billion
Q4 2022

May 10, 2024
BUY
$9.89 - $12.7 $9,365 - $12,026
947 Added 0.65%
146,423 $1.79 Million
Q4 2022

Mar 22, 2023
BUY
$9.89 - $12.7 $9,365 - $12,026
947 Added 0.65%
146,423 $1.79 Million
Q4 2022

Feb 15, 2023
BUY
$9.89 - $12.7 $9,365 - $12,026
947 Added 0.65%
146,423 $1.79 Million
Q3 2022

Jun 14, 2023
SELL
$9.82 - $12.75 $9,299 - $12,074
-947 Reduced 0.65%
145,476 $1.52 Million
Q2 2022

Jun 20, 2023
SELL
$6.23 - $11.12 $5,899 - $10,530
-947 Reduced 0.65%
145,476 $1.56 Million
Q1 2022

May 10, 2024
BUY
$7.89 - $12.48 $1.15 Million - $1.82 Million
145,476 New
145,476 $1.38 Million
Q1 2022

Jun 20, 2023
SELL
$7.89 - $12.48 $7,471 - $11,818
-947 Reduced 0.65%
145,476 $1.38 Million
Q1 2022

Mar 22, 2023
BUY
$7.89 - $12.48 $399,234 - $631,488
50,600 Added 53.33%
145,476 $1.38 Million
Q1 2022

May 12, 2022
BUY
$7.89 - $12.48 $399,234 - $631,488
50,600 Added 53.33%
145,476 $1.38 Million
Q4 2021

Jun 21, 2023
SELL
$9.82 - $12.44 $506,191 - $641,244
-51,547 Reduced 35.2%
94,876 $1.1 Million
Q3 2021

Jun 21, 2023
SELL
$8.74 - $11.84 $450,520 - $610,316
-51,547 Reduced 35.2%
94,876 $906,000
Q2 2021

May 17, 2024
BUY
$8.71 - $10.72 $99,503 - $122,465
11,424 Added 13.69%
94,876 $914,000
Q2 2021

Jun 21, 2023
SELL
$8.71 - $10.72 $448,974 - $552,583
-51,547 Reduced 35.2%
94,876 $914,000
Q2 2021

Mar 22, 2023
BUY
$8.71 - $10.72 $99,503 - $122,465
11,424 Added 13.69%
94,876 $914,000
Q2 2021

Aug 16, 2021
BUY
$8.71 - $10.72 $99,503 - $122,465
11,424 Added 13.69%
94,876 $915,000
Q1 2021

May 17, 2024
SELL
$9.2 - $23.86 $567,253 - $1.47 Million
-61,658 Reduced 42.49%
83,452 $824,000
Q1 2021

Jun 26, 2023
SELL
$9.2 - $23.86 $579,333 - $1.5 Million
-62,971 Reduced 43.01%
83,452 $825 Million
Q1 2021

Mar 22, 2023
SELL
$9.2 - $23.86 $195,463 - $506,929
-21,246 Reduced 20.29%
83,452 $824,000
Q1 2021

May 14, 2021
SELL
$9.2 - $23.86 $195,463 - $506,929
-21,246 Reduced 20.29%
83,452 $825,000
Q4 2020

May 24, 2024
SELL
$13.47 - $24.89 $107,531 - $198,696
-7,983 Reduced 7.08%
104,698 $2.42 Million
Q4 2020

Jun 22, 2023
SELL
$13.47 - $24.89 $562,035 - $1.04 Million
-41,725 Reduced 28.5%
104,698 $2.42 Million
Q4 2020

Mar 22, 2023
SELL
$13.47 - $24.89 $107,531 - $198,696
-7,983 Reduced 7.08%
104,698 $2.42 Million
Q4 2020

Feb 16, 2021
SELL
$13.47 - $24.89 $107,531 - $198,696
-7,983 Reduced 7.08%
104,698 $2.42 Million
Q3 2020

Jun 26, 2023
SELL
$12.89 - $15.89 $434,934 - $536,160
-33,742 Reduced 23.04%
112,681 $1.59 Million
Q2 2020

May 24, 2024
SELL
$8.86 - $15.69 $287,320 - $508,811
-32,429 Reduced 22.35%
112,681 $1.7 Billion
Q2 2020

Jun 26, 2023
SELL
$8.86 - $15.69 $298,954 - $529,411
-33,742 Reduced 23.04%
112,681 $1.7 Million
Q1 2020

Jul 12, 2023
SELL
$6.63 - $11.16 $223,709 - $376,560
-33,742 Reduced 23.04%
112,681 $1.04 Million
Q4 2019

Jul 12, 2023
SELL
$7.48 - $10.75 $252,390 - $362,726
-33,742 Reduced 23.04%
112,681 $1.1 Million
Q3 2019

Jul 12, 2023
SELL
$8.02 - $13.25 $270,610 - $447,081
-33,742 Reduced 23.04%
112,681 $903,000
Q3 2019

Mar 22, 2023
BUY
$8.02 - $13.25 $216,195 - $357,180
26,957 Added 31.45%
112,681 $903,000
Q3 2019

Nov 14, 2019
BUY
$8.02 - $13.25 $216,195 - $357,180
26,957 Added 31.45%
112,681 $904,000
Q2 2019

Jul 12, 2023
SELL
$10.96 - $14.4 $464,572 - $610,387
-42,388 Reduced 28.95%
104,035 $1.3 Million
Q1 2019

Jul 13, 2023
SELL
$10.04 - $13.92 $609,417 - $844,930
-60,699 Reduced 41.45%
85,724 $1.17 Million
Q4 2018

Jul 13, 2023
SELL
$8.38 - $13.44 $508,657 - $815,794
-60,699 Reduced 41.45%
85,724 $821,000
Q4 2018

Mar 22, 2023
SELL
$8.38 - $13.44 $398,569 - $639,233
-47,562 Reduced 35.68%
85,724 $821,000
Q4 2018

Feb 14, 2019
SELL
$8.38 - $13.44 $398,569 - $639,233
-47,562 Reduced 35.68%
85,724 $821,000
Q3 2018

Jul 13, 2023
SELL
$11.6 - $16.54 $704,108 - $1 Million
-60,699 Reduced 41.45%
85,724 $1.04 Million
Q3 2018

Mar 22, 2023
SELL
$11.6 - $16.54 $152,389 - $217,285
-13,137 Reduced 8.97%
133,286 $1.61 Million
Q3 2018

Nov 14, 2018
BUY
$11.6 - $16.54 $551,719 - $786,675
47,562 Added 55.48%
133,286 $1.61 Million
Q1 2018

May 15, 2018
BUY
$13.76 - $17.12 $120,207 - $149,560
8,736 Added 11.35%
85,724 $1.29 Million
Q4 2017

Feb 15, 2018
BUY
$12.51 - $16.24 $963,119 - $1.25 Million
76,988
76,988 $1.11 Million

Others Institutions Holding FOLD

# of Institutions
309
Shares Held
283M
Call Options Held
467K
Put Options Held
515K
View Full List

About AMICUS THERAPEUTICS, INC.

FOLD Quotes by TradingView
  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $1.92B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email